Calcium-stimulated insulin secretion in diffuse and focal forms of congenital hyperinsulinism - 05/09/11
Abstract |
Objectives: To identify infants with hyperinsulinism caused by defects of the β-cell adenosine triphosphate-dependent potassium channel complex and to distinguish focal and diffuse forms of hyperinsulinism caused by these mutations. Study design: The acute insulin response to intravenous calcium stimulation (CaAIR) was determined in 9 patients <20 years with diffuse hyperinsulinism caused by defective β-cell sulfonylurea receptor (SUR1 –/–), 3 patients with focal congenital hyperinsulinism (6 weeks to 18 months), a 10-year-old with insulinoma, 5 with hyperinsulinism/hyperammonemia syndrome caused by defective glutamate dehydrogenase (6 months to 28 years), 4 SUR1 +/– heterozygotes with no symptoms, and 9 normal adults. Three infants with congenital focal disease, 1 with diffuse hyperinsulinism, and the child with insulinoma underwent selective pancreatic intra-arterial calcium stimulation with hepatic venous sampling. Results: Children with diffuse SUR1 –/– disease and infants with congenital focal hyperinsulinism responded to CaAIR, whereas the normal control group, patients with hyperinsulinism/hyperammonemia syndrome, and SUR1 +/– carriers did not. Selective arterial calcium stimulation of the pancreas with hepatic venous sampling revealed selective, significant step-ups in insulin secretion that correlated anatomically with the location of solitary lesions confirmed surgically in 2 of 3 infants with congenital focal disease and in the child with insulinoma. Selective arterial calcium stimulation of the pancreas with hepatic venous sampling demonstrated markedly elevated baseline insulin levels throughout the pancreas of the infant with diffuse hyperinsulinism. Conclusions: The intravenous CaAIR is a safe and simple test for identifying infants with diffuse SUR1 –/– hyperinsulinism or with focal congenital hyperinsulinism. Preoperative selective arterial calcium stimulation of the pancreas with hepatic venous sampling can localize focal lesions causing hyperinsulinism in children. The combination of these calcium stimulation tests may help distinguish focal lesions suitable for cure by local surgical resection. (J Pediatr 2000;137:239-46)
Le texte complet de cet article est disponible en PDF.Abbreviations : ASVS, CaAIR, HI/HA, KATP, Kir6.2, SMA, SPL, SUR1
Plan
Supported in part by National Institutes of Health grants R01 DK53012 and R01 DK56268 (to C.A.S.) and T32 DK07314 (to R.J.F., A.K., A.G.), GCRC grant M01 RR00240 (to C.A.S.), American Diabetes Association Research Grants (to C.A.S., L.A.B.), Houston Endowment (L.A.B.), Baylor College of Medicine (L.A.B.), Israel Ministry of Health Grant No. 4201 (B.G), a grant from the Israel Science Foundation founded by the Academy of Sciences and Humanities (B.G.), and Lawson Wilkins Pediatric Endocrine Society Research Fellowships (Pharmacia & Upjohn Award to R.J.F. and Eli Lilly & Co. Award to A.G.). |
|
Reprint requests: Charles A. Stanley, MD, Division of Endocrinology & Diabetes, The Children's Hospital of Philadelphia, Abramson Pediatric Research Center, Room 410, 3615 Civic Center Blvd, Philadelphia, PA 19104-4318. |
Vol 137 - N° 2
P. 239-246 - août 2000 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?